Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial

IMPORTANCE: Azithromycin has been hypothesized to have activity against SARS-CoV-2. OBJECTIVE: To determine whether oral azithromycin in outpatients with SARS-CoV-2 infection leads to absence of self-reported COVID-19 symptoms at day 14. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:JAMA
Hauptverfasser: Oldenburg, Catherine E., Pinsky, Benjamin A., Brogdon, Jessica, Chen, Cindi, Ruder, Kevin, Zhong, Lina, Nyatigo, Fanice, Cook, Catherine A., Hinterwirth, Armin, Lebas, Elodie, Redd, Travis, Porco, Travis C., Lietman, Thomas M., Arnold, Benjamin F., Doan, Thuy
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Medical Association 2021
Schlagworte:
Original Investigation
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8285753/
https://ncbi.nlm.nih.gov/pubmed/34269813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2021.11517
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge